Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Beclometasone Dipropionate Inhalation Aerosol

Approval Number

国药准字H44024063

Company广东松下药业有限公司

Registration Date

January 6, 2021

Previous Approval Numbers

国药准字H44024063

Drug Information

Generic Name

丙酸倍氯米松气雾剂

Dosage Form

气雾剂

Strength

每瓶200揿,每揿含丙酸倍氯米松50ug

Drug Type

化学药品

Registration Date

January 6, 2021

Company Information

Applicant Company

Company Name广东松下药业有限公司

Company Address

普宁市大南山街道工业区河滨北028A幢

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

丙酸倍氯米松气雾剂 - NMPA 批准文号 | MedPath